Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 October 2020 | Story Nitha Ramnath

The National Student Entrepreneurship Week (#SEW2020) is a project of Entrepreneurship Development in Higher Education (EDHE) in collaboration with Universities South Africa (USAf). 

The University of the Free State (UFS) has been selected to host the National Student Entrepreneurship Week from 2 to 4 November 2020. The programme is presented virtually and will be streamed by the UFS from 2 to 4 November; the events can be accessed live on the Whova app and on Facebook: @EDHEStudententrepreneurship, allowing students to watch at their convenience.

Background of SEW 2020

The National Student Entrepreneurship Week was piloted in 2017 and successfully executed in 2018 by the public universities and TVET colleges. This year, themed #AfroTech, #SEW2020 aims to gain participation from all (26) public universities and TVET colleges.

Objectives of SEW 2020

The objectives of Student Entrepreneurship Week are to raise awareness among students that participation in the economy is not necessarily only through the avenue of formal employment. Students are encouraged to develop innovative and creative ideas to solve many problems facing society. This year, the event allows universities and TVET colleges to showcase the different entrepreneurial activities and achievements of their institutions, which are intended to raise awareness and inspire students towards entrepreneurship and emphasising the benefits of having the best of both worlds as a student and as an entrepreneur.

Format of event

The event promises to offer a high-impact experience that will be easily accessible virtually, with multi-institutional participation and collaboration nationally. Participating universities will contribute to the content of the programme, which will be curated by the EDHE and livestreamed by the EDHE production partner.

The virtual format of the event allows students to preselect sessions in order to create a personalised experience that is customised for their personal schedules and circumstances. Students can watch the live stream as well as missed sessions on YouTube, and further engage with their own institution or with EDHE on social media.

More information on the Student Entrepreneurship Week can be found at  https://edhe.co.za/

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept